Arch Venture Management, LLC Karuna Therapeutics, Inc. Transaction History

Arch Venture Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$161.33 - $204.36 $77.9 Million - $98.7 Million	-482,872 Reduced 94.15%	30,000 $5.45 Million
Q4 2022 Feb 14, 2023	SELL	$191.53 - $236.82 $153 Million - $189 Million	-800,000 Reduced 60.94%	512,872 $101 Million
Q3 2022 Nov 10, 2022	SELL	$123.79 - $277.42 $198 Million - $444 Million	-1,600,000 Reduced 54.93%	1,312,872 $295 Million
Q4 2021 Feb 14, 2022	BUY	$110.64 - $159.4 $322 Million - $464 Million	2,912,872 New	2,912,872 $382 Million

332K

Ticker KRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,965,000
Description
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that is in Phase III clinical trial for the treatment of acute psychosis in patients wi...

Get notified when there are updates to the investment portfolio of Arch Venture Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Arch Venture Management, LLC with notifications on news.